Responses
Immune cell therapies and immune cell engineering
Original research
Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
